Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects

被引:0
|
作者
Wenjia Zhou
Chengzhe Lv
Quanying Zhang
Shunlin Zong
Meng Wang
机构
[1] The Second Affiliated Hospital of Soochow University,Clinical Pharmacology Laboratory
[2] Children’s Hospital of Soochow University,Department of Pharmaceutics
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:125 / 133
页数:8
相关论文
共 50 条
  • [41] Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects
    Tsuda, Yasuhiro
    Grimaldi, Christine
    Huang, Fenglei
    Benediktus, Ewald
    Yagi, Nobutaka
    Padula, Steven J.
    Jang, In-Jin
    Steffgen, Jurgen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 2000 - 2013
  • [42] Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of CMAB807, a New Denosumab Biosimilar, in Healthy Chinese Subjects
    Chen, Hanjing
    Chen, Weili
    Yuan, Fei
    Guo, Qingcheng
    Zhang, Xunmin
    Wang, Chenguang
    Li, Xuening
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [43] Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg, a pegfilgrastim biosimilar in healthy subjects
    Roth, Karsten
    Lehnick, Dirk
    Wessels, Hendrik
    Hoefler, Josef
    Gastl, Barbara
    Jankowsky, Ruediger
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (05):
  • [44] Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects
    Liechti, Matthias E.
    Quednow, Boris B.
    Liakoni, Evangelia
    Dornbierer, Dario
    von Rotz, Robin
    Gachet, Maria Salome
    Gertsch, Jurg
    Seifritz, Erich
    Bosch, Oliver G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (05) : 980 - 988
  • [45] Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects
    Marino, MR
    Langenbacher, K
    Ford, NF
    Uderman, HD
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (03): : 246 - 255
  • [46] The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects.
    Small, D. S.
    Kothare, P. A.
    Yuen, E. S.
    Li, Y. G.
    Winters, K. J.
    Farid, N. A.
    Ni, L.
    Salazar, D. E.
    Payne, C. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S56 - S57
  • [47] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF LEMBOREXANT IN HEALTHY CHINESE SUBJECTS
    Moline, M.
    Nakai, K.
    Morita, M.
    Zhao, T.
    Takese, T.
    Cheng, J. Y.
    Yun, L.
    SLEEP MEDICINE, 2022, 100 : S132 - S133
  • [48] Pharmacokinetics and safety of repirinast tablets in healthy Chinese subjects
    Lv, Cheng-Zhe
    Huang, Ming
    Zhang, Quan-Ying
    Zong, Shun-Lin
    Wang, Meng
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 54 (02)
  • [49] Fosinopril: Pharmacokinetics and pharmacodynamics in Chinese subjects
    Ding, PYA
    Chu, KM
    Hu, OYP
    Huang, GM
    Jeng, JJ
    Chang, A
    Delaney, CL
    MacAskill, M
    Yang, BC
    Jemal, M
    Smith, R
    Liao, WC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (02): : 155 - 160
  • [50] The pharmacokinetics and pharmacodynamics of fentanyl administered via transdermal patch in horses
    Reed, Rachel A.
    Berghaus, Londa J.
    Reynolds, Rose M.
    Holmes, Brittany T.
    Krikorian, Anna M.
    Sakai, Daniel M.
    Ishikawa, Yushun
    Knych, Heather K.
    FRONTIERS IN PAIN RESEARCH, 2024, 5